131 related articles for article (PubMed ID: 1920859)
1. [Plasma factor VII levels in disseminated intravascular coagulation].
Kario K; Matsuo T; Yamamoto K; Kobayashi H
Rinsho Byori; 1991 Jul; 39(7):683-8. PubMed ID: 1920859
[TBL] [Abstract][Full Text] [Related]
2. [Factor VII for a molecular marker in hypercoagulable state].
Takamiya O; Okumura N
Rinsho Byori; 1993 Jan; 41(1):83-7. PubMed ID: 8355413
[TBL] [Abstract][Full Text] [Related]
3. Factor VII hyperactivity in the elderly.
Kario K; Matsuo T; Nakao K
Thromb Haemost; 1991 Jan; 65(1):25-7. PubMed ID: 2024236
[TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
5. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
8. [Clinical application of laboratory diagnosis: leukemia and DIC].
Deguchi K; Zhao LJ; Shirakawa S
Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
[TBL] [Abstract][Full Text] [Related]
9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
11. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant.
Humphries S; Temple A; Lane A; Green F; Cooper J; Miller G
Thromb Haemost; 1996 Apr; 75(4):567-72. PubMed ID: 8743180
[TBL] [Abstract][Full Text] [Related]
12. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
[TBL] [Abstract][Full Text] [Related]
15. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
18. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
19. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
Cai Q; Chen J; Ma H; Song J; Xu M
Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
[TBL] [Abstract][Full Text] [Related]
20. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]